Index by author

01 March 2010; volume 35, issue 3

A

  1. Abubakar, I.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  2. Agten, A.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  3. Ahn, Y.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  4. Alison, J. A.

    1. Spencer, L. M., J. A. Alison, and Z. J. McKeough. "Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial." European Respiratory Journal 35.3 (2010): 571-577. Web. 28 Feb. 2021.

  5. Allix-Béguec, C.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  6. Alsina, M.

    1. Calbo, E. et al "The impact of time on the systemic inflammatory response in pneumococcal pneumonia." European Respiratory Journal 35.3 (2010): 614-618. Web. 28 Feb. 2021.

  7. Andrews, N.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  8. Arzt, M.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  9. Astoul, P.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  10. Aukrust, P.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

B

  1. Baas, P.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  2. Bai, C.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

  3. Baines, K. J.

    1. Baines, K. J. et al "Differential gene expression and cytokine production from neutrophils in asthma phenotypes." European Respiratory Journal 35.3 (2010): 522-531. Web. 28 Feb. 2021.

  4. Bakke, P. S.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

  5. Ballmann, M.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  6. Barreto, M. L.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  7. Baseke, J.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  8. Belenkie, I.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  9. Belvisi, M. G.

    1. Freund-Michel, V. C. et al "β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway." European Respiratory Journal 35.3 (2010): 647-654. Web. 28 Feb. 2021.

  10. Berghmans, T.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  11. Birrell, M. A.

    1. Freund-Michel, V. C. et al "β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway." European Respiratory Journal 35.3 (2010): 647-654. Web. 28 Feb. 2021.

  12. Bothamley, G.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  13. Bouros, D.

    1. Tsangaris, I., S. Orfanos, and D. Bouros. "Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification." European Respiratory Journal 35.3 (2010): 700-701. Web. 28 Feb. 2021.

  14. Bousquet, J.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  15. Bowden, N. A.

    1. Baines, K. J. et al "Differential gene expression and cytokine production from neutrophils in asthma phenotypes." European Respiratory Journal 35.3 (2010): 522-531. Web. 28 Feb. 2021.

  16. Bracke, K. R.

    1. Demoor, T. et al "Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD." European Respiratory Journal 35.3 (2010): 688-689. Web. 28 Feb. 2021.

  17. Bradley, T. D.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  18. Briggs, A. H.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  19. Brusasco, V.

    1. Brusasco, V., and A. T. Dinh-Xuan. "Stereology: a bridge to a better understanding of lung structure and function." European Respiratory Journal 35.3 (2010): 477-478. Web. 28 Feb. 2021.
    2. Dinh-Xuan, A. T., and V. Brusasco. " From the Editors: ." European Respiratory Journal 35.3 (2010): 699-700. Web. 28 Feb. 2021.

  20. Brusselle, G. G.

    1. Demoor, T. et al "Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD." European Respiratory Journal 35.3 (2010): 688-689. Web. 28 Feb. 2021.

C

  1. Cadranel, J.

    1. Lioté, H. et al "Rituximab-induced lung disease: a systematic literature review." European Respiratory Journal 35.3 (2010): 681-687. Web. 28 Feb. 2021.

  2. Calbo, E.

    1. Calbo, E. et al "The impact of time on the systemic inflammatory response in pneumococcal pneumonia." European Respiratory Journal 35.3 (2010): 614-618. Web. 28 Feb. 2021.

  3. Calverley, P. M. A.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  4. Chanez, P.

    1. Gernez, Y., R. Tirouvanziam, and P. Chanez. "Neutrophils in chronic inflammatory airway diseases: can we target them and how?." European Respiratory Journal 35.3 (2010): 467-469. Web. 28 Feb. 2021.

  5. Chang, H.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  6. Chang, K. C.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  7. Chang, L. W.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  8. Clayson, H.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  9. Crimi, N.

    1. Vancheri, C. et al "Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology." European Respiratory Journal 35.3 (2010): 496-504. Web. 28 Feb. 2021.

  10. Crombach, M.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  11. Crul, T.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  12. Cruz, A. A.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  13. Curjuric, I.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

D

  1. Damås, J. K.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

  2. Decramer, M.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  3. Demoor, T.

    1. Demoor, T. et al "Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD." European Respiratory Journal 35.3 (2010): 688-689. Web. 28 Feb. 2021.

  4. de Vuyst, P.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  5. Dienemann, H.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  6. Dinh-Xuan, A. T.

    1. Brusasco, V., and A. T. Dinh-Xuan. "Stereology: a bridge to a better understanding of lung structure and function." European Respiratory Journal 35.3 (2010): 477-478. Web. 28 Feb. 2021.
    2. Dinh-Xuan, A. T., and V. Brusasco. " From the Editors: ." European Respiratory Journal 35.3 (2010): 699-700. Web. 28 Feb. 2021.

  7. Downs, S.H.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  8. Dupont, L. J.

    1. Goeminne, P. C., and L. J. Dupont. "The sinusitis-infertility syndrome: Young's saint, old devil." European Respiratory Journal 35.3 (2010): 698. Web. 28 Feb. 2021.

E

  1. Eagan, T. M. L.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

  2. Ernst, M.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  3. Ewig, S.

    1. von Baum, H. et al "Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors." European Respiratory Journal 35.3 (2010): 598-615. Web. 28 Feb. 2021.

F

  1. Failla, M.

    1. Vancheri, C. et al "Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology." European Respiratory Journal 35.3 (2010): 496-504. Web. 28 Feb. 2021.

  2. Fauroux, B.

    1. Louis, B. et al "Effect of manufacturer-inserted mask leaks on ventilator performance." European Respiratory Journal 35.3 (2010): 627-636. Web. 28 Feb. 2021.

  3. Fauville-Dufaux, M.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  4. Ferguson, K. A.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  5. Fink, L.

    1. Wolff, J-C. et al "Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth." European Respiratory Journal 35.3 (2010): 655-666. Web. 28 Feb. 2021.

  6. Fleetham, J.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  7. Floras, J. S.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  8. Franco, R.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  9. Freund-Michel, V. C.

    1. Freund-Michel, V. C. et al "β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway." European Respiratory Journal 35.3 (2010): 647-654. Web. 28 Feb. 2021.

G

  1. Galateau-Salle, F.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  2. Garau, J.

    1. Calbo, E. et al "The impact of time on the systemic inflammatory response in pneumococcal pneumonia." European Respiratory Journal 35.3 (2010): 614-618. Web. 28 Feb. 2021.

  3. Gayan-Ramirez, G.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  4. Gernez, Y.

    1. Gernez, Y., R. Tirouvanziam, and P. Chanez. "Neutrophils in chronic inflammatory airway diseases: can we target them and how?." European Respiratory Journal 35.3 (2010): 467-469. Web. 28 Feb. 2021.

  5. Gibson, P. G.

    1. Baines, K. J. et al "Differential gene expression and cytokine production from neutrophils in asthma phenotypes." European Respiratory Journal 35.3 (2010): 522-531. Web. 28 Feb. 2021.

  6. Giehl, C.

    1. Sester, M. et al "Management of tuberculosis in HIV infection: where T-cells matter." European Respiratory Journal 35.3 (2010): 475-476. Web. 28 Feb. 2021.

  7. Giembycz, M. A.

    1. Freund-Michel, V. C. et al "β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway." European Respiratory Journal 35.3 (2010): 647-654. Web. 28 Feb. 2021.

  8. Glick, H. A.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  9. Goeminne, P. C.

    1. Goeminne, P. C., and L. J. Dupont. "The sinusitis-infertility syndrome: Young's saint, old devil." European Respiratory Journal 35.3 (2010): 698. Web. 28 Feb. 2021.

  10. Goletti, D.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  11. Goolaerts, A.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

H

  1. Haj-Yahia, S.

    1. Freund-Michel, V. C. et al "β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway." European Respiratory Journal 35.3 (2010): 647-654. Web. 28 Feb. 2021.

  2. Hanly, P. J.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  3. Hardie, J. A.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

  4. Hayward, A.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  5. Hebestreit, A.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  6. Hebestreit, H.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  7. Hele, D. J.

    1. Freund-Michel, V. C. et al "β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway." European Respiratory Journal 35.3 (2010): 647-654. Web. 28 Feb. 2021.

  8. Hennequin, C.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  9. Hersberger, M.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  10. Hillerdal, G.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  11. Hirsch, C.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  12. Hogaboam, C.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  13. Holz, O.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  14. Hong, Q.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

  15. Hopkins, S. R.

    1. Hopkins, S. R.. "Stress failure and high-altitude pulmonary oedema: mechanistic insights from physiology." European Respiratory Journal 35.3 (2010): 470-472. Web. 28 Feb. 2021.

I

  1. Illi, S.

    1. Matricardi, P. M. et al "Predicting persistence of wheezing: one algorithm does not fit all." European Respiratory Journal 35.3 (2010): 701-703. Web. 28 Feb. 2021.

  2. Imboden, M.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  3. Isabey, D.

    1. Louis, B. et al "Effect of manufacturer-inserted mask leaks on ventilator performance." European Respiratory Journal 35.3 (2010): 627-636. Web. 28 Feb. 2021.

J

  1. Jones, P. W.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  2. Joos, G. F.

    1. Demoor, T. et al "Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD." European Respiratory Journal 35.3 (2010): 688-689. Web. 28 Feb. 2021.

  3. Junge, S.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

K

  1. Kamio, K.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  2. Kawasaki, S.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  3. Keil, T.

    1. Matricardi, P. M. et al "Predicting persistence of wheezing: one algorithm does not fit all." European Respiratory Journal 35.3 (2010): 701-703. Web. 28 Feb. 2021.

  4. Khalilieh, S.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  5. Kieser, S.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  6. Kimoff, R. J.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  7. Koss, M. N.

    1. Shigemitsu, H. et al "Chronic interstitial pneumonitis in end-stage sarcoidosis." European Respiratory Journal 35.3 (2010): 695-697. Web. 28 Feb. 2021.

  8. Kriemler, S.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

L

  1. Lam, H. C.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  2. Lange, C.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  3. Lau, S.

    1. Matricardi, P. M. et al "Predicting persistence of wheezing: one algorithm does not fit all." European Respiratory Journal 35.3 (2010): 701-703. Web. 28 Feb. 2021.

  4. Lau, T. Y.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  5. Lee, S. N.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  6. Leidl, L.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  7. Le Péchoux, C.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  8. Leroux, K.

    1. Louis, B. et al "Effect of manufacturer-inserted mask leaks on ventilator performance." European Respiratory Journal 35.3 (2010): 627-636. Web. 28 Feb. 2021.

  9. Leroy, M.

    1. Raffestin, B., and M. Leroy. "Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension." European Respiratory Journal 35.3 (2010): 704-705. Web. 28 Feb. 2021.

  10. Leung, C. C.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  11. Leung, W. M.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  12. Lin, P.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  13. Lioté, F.

    1. Lioté, H. et al "Rituximab-induced lung disease: a systematic literature review." European Respiratory Journal 35.3 (2010): 681-687. Web. 28 Feb. 2021.

  14. Lioté, H.

    1. Lioté, H. et al "Rituximab-induced lung disease: a systematic literature review." European Respiratory Journal 35.3 (2010): 681-687. Web. 28 Feb. 2021.

  15. Lipman, M.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  16. Lite, J.

    1. Calbo, E. et al "The impact of time on the systemic inflammatory response in pneumococcal pneumonia." European Respiratory Journal 35.3 (2010): 614-618. Web. 28 Feb. 2021.

  17. Liu, S.L.J.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  18. Liu, X. D.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  19. Livermore, N.

    1. Livermore, N., L. Sharpe, and D. McKenzie. "Prevention of panic attacks and panic disorder in COPD." European Respiratory Journal 35.3 (2010): 557-563. Web. 28 Feb. 2021.

  20. Lofaso, F.

    1. Louis, B. et al "Effect of manufacturer-inserted mask leaks on ventilator performance." European Respiratory Journal 35.3 (2010): 627-636. Web. 28 Feb. 2021.

  21. Logan, A. G.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  22. Louis, B.

    1. Louis, B. et al "Effect of manufacturer-inserted mask leaks on ventilator performance." European Respiratory Journal 35.3 (2010): 627-636. Web. 28 Feb. 2021.

  23. Lozano-Ortega, G.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  24. Ludwig-Sengpiel, A.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

M

  1. Ma, Y. H.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  2. Macklem, P. T.

    1. Macklem, P. T.. "Therapeutic implications of the pathophysiology of COPD." European Respiratory Journal 35.3 (2010): 676-680. Web. 28 Feb. 2021.

  3. Maes, K.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  4. Magnussen, H.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  5. Marre, R.

    1. von Baum, H. et al "Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors." European Respiratory Journal 35.3 (2010): 598-615. Web. 28 Feb. 2021.

  6. Matricardi, P. M.

    1. Matricardi, P. M. et al "Predicting persistence of wheezing: one algorithm does not fit all." European Respiratory Journal 35.3 (2010): 701-703. Web. 28 Feb. 2021.

  7. Matyas, G.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  8. Mayanja-Kizza, H.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  9. Mayaud, C.

    1. Lioté, H. et al "Rituximab-induced lung disease: a systematic literature review." European Respiratory Journal 35.3 (2010): 681-687. Web. 28 Feb. 2021.

  10. McKenzie, D.

    1. Livermore, N., L. Sharpe, and D. McKenzie. "Prevention of panic attacks and panic disorder in COPD." European Respiratory Journal 35.3 (2010): 557-563. Web. 28 Feb. 2021.

  11. McKeough, Z. J.

    1. Spencer, L. M., J. A. Alison, and Z. J. McKeough. "Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial." European Respiratory Journal 35.3 (2010): 571-577. Web. 28 Feb. 2021.

  12. Menéndez, R.

    1. Torres, A., and R. Menéndez. "Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?." European Respiratory Journal 35.3 (2010): 473-474. Web. 28 Feb. 2021.

  13. Meyerhans, A.

    1. Sester, M. et al "Management of tuberculosis in HIV infection: where T-cells matter." European Respiratory Journal 35.3 (2010): 475-476. Web. 28 Feb. 2021.

  14. Mollnes, T. E.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

  15. Morrison, D.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  16. Mutti, L.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

N

  1. Naeije, R.

    1. Naeije, R., and P. van de Borne. " From the authors: ." European Respiratory Journal 35.3 (2010): 705. Web. 28 Feb. 2021.

  2. Nava, S.

    1. , and S. Nava. "Pulmonologists and intensivists: “two hearts are better than one”." European Respiratory Journal 35.3 (2010): 463-466. Web. 28 Feb. 2021.

O

  1. Oblad, J. M.

    1. Shigemitsu, H. et al "Chronic interstitial pneumonitis in end-stage sarcoidosis." European Respiratory Journal 35.3 (2010): 695-697. Web. 28 Feb. 2021.

  2. Ommeslag, D.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  3. Orfanos, S.

    1. Tsangaris, I., S. Orfanos, and D. Bouros. "Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification." European Respiratory Journal 35.3 (2010): 700-701. Web. 28 Feb. 2021.

P

  1. Pairon, J-C.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  2. Pelosi, P.

    1. , and S. Nava. "Pulmonologists and intensivists: “two hearts are better than one”." European Respiratory Journal 35.3 (2010): 463-466. Web. 28 Feb. 2021.

  3. Pfeifer, M.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  4. Ponte, E. V.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  5. Posselt, H-G.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  6. Postma, D.S.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  7. Probst-Hensch, N.M.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

Q

  1. Quanjer, P.

    1. Quanjer, P.. "Submitting a manuscript." European Respiratory Journal 35.3 (2010): 699. Web. 28 Feb. 2021.

R

  1. Raffestin, B.

    1. Raffestin, B., and M. Leroy. "Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension." European Respiratory Journal 35.3 (2010): 704-705. Web. 28 Feb. 2021.

  2. Raghu, G.

    1. Vancheri, C. et al "Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology." European Respiratory Journal 35.3 (2010): 496-504. Web. 28 Feb. 2021.

  3. Rennard, S. I.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  4. Rochat, T.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  5. Rodrigues, L. C.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  6. Rodríguez-Carballeira, M.

    1. Calbo, E. et al "The impact of time on the systemic inflammatory response in pneumococcal pneumonia." European Respiratory Journal 35.3 (2010): 614-618. Web. 28 Feb. 2021.

  7. Russi, E.W.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  8. Ryan, C. M.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

S

  1. Sadeh, J.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  2. Saegerman, C.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  3. Schenk, T.

    1. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  4. Scherpereel, A.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  5. Schindler, C.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.
    2. Hebestreit, H. et al "Long-term effects of a partially supervised conditioning programme in cystic fibrosis." European Respiratory Journal 35.3 (2010): 578-583. Web. 28 Feb. 2021.

  6. Schwartz, J.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  7. Scott, R. J.

    1. Baines, K. J. et al "Differential gene expression and cytokine production from neutrophils in asthma phenotypes." European Respiratory Journal 35.3 (2010): 522-531. Web. 28 Feb. 2021.

  8. Seeger, W.

    1. Wolff, J-C. et al "Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth." European Respiratory Journal 35.3 (2010): 655-666. Web. 28 Feb. 2021.

  9. Series, F.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  10. Séroussi, B.

    1. Lioté, H. et al "Rituximab-induced lung disease: a systematic literature review." European Respiratory Journal 35.3 (2010): 681-687. Web. 28 Feb. 2021.

  11. Sester, M.

    1. Sester, M. et al "Management of tuberculosis in HIV infection: where T-cells matter." European Respiratory Journal 35.3 (2010): 475-476. Web. 28 Feb. 2021.

  12. Sester, U.

    1. Sester, M. et al "Management of tuberculosis in HIV infection: where T-cells matter." European Respiratory Journal 35.3 (2010): 475-476. Web. 28 Feb. 2021.

  13. Sharma, O. P.

    1. Shigemitsu, H. et al "Chronic interstitial pneumonitis in end-stage sarcoidosis." European Respiratory Journal 35.3 (2010): 695-697. Web. 28 Feb. 2021.

  14. Sharpe, L.

    1. Livermore, N., L. Sharpe, and D. McKenzie. "Prevention of panic attacks and panic disorder in COPD." European Respiratory Journal 35.3 (2010): 557-563. Web. 28 Feb. 2021.

  15. She, J.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

  16. Shen, C.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

  17. Shen, J.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

  18. Shigemitsu, H.

    1. Shigemitsu, H. et al "Chronic interstitial pneumonitis in end-stage sarcoidosis." European Respiratory Journal 35.3 (2010): 695-697. Web. 28 Feb. 2021.

  19. Simpson, J. L.

    1. Baines, K. J. et al "Differential gene expression and cytokine production from neutrophils in asthma phenotypes." European Respiratory Journal 35.3 (2010): 522-531. Web. 28 Feb. 2021.

  20. Smilovitch, M.

    1. Ryan, C. M. et al "Shift in sleep apnoea type in heart failure patients in the CANPAP trial." European Respiratory Journal 35.3 (2010): 592-597. Web. 28 Feb. 2021.

  21. Song, Y.

    1. Bai, C. et al "Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats." European Respiratory Journal 35.3 (2010): 584-591. Web. 28 Feb. 2021.

  22. Soni, P.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  23. Sotgiu, G.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  24. Souza-Machado, A.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  25. Souza-Machado, C.

    1. Souza-Machado, C. et al "Rapid reduction in hospitalisations after an intervention to manage severe asthma." European Respiratory Journal 35.3 (2010): 515-521. Web. 28 Feb. 2021.

  26. Spencer, L. M.

    1. Spencer, L. M., J. A. Alison, and Z. J. McKeough. "Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial." European Respiratory Journal 35.3 (2010): 571-577. Web. 28 Feb. 2021.

  27. Spencer, M.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  28. Stahel, R.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  29. Stoffels, K.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  30. Story, A.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  31. Stryszak, P.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  32. Sugiura, H.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  33. Supply, P.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  34. Suttorp, N.

    1. von Baum, H. et al "Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors." European Respiratory Journal 35.3 (2010): 598-615. Web. 28 Feb. 2021.

T

  1. Tam, C. M.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  2. Testelmans, D.

    1. Testelmans, D. et al "Atrophy and hypertrophy signalling in the diaphragm of patients with COPD." European Respiratory Journal 35.3 (2010): 549-556. Web. 28 Feb. 2021.

  3. Thun, G.A.

    1. Curjuric, I. et al "HMOX1 and GST variants modify attenuation of FEF25–75% decline due to PM10 reduction." European Respiratory Journal 35.3 (2010): 505-514. Web. 28 Feb. 2021.

  4. Tirouvanziam, R.

    1. Gernez, Y., R. Tirouvanziam, and P. Chanez. "Neutrophils in chronic inflammatory airway diseases: can we target them and how?." European Respiratory Journal 35.3 (2010): 467-469. Web. 28 Feb. 2021.

  5. Togo, S.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  6. Toossi, Z.

    1. Leidl, L. et al "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection." European Respiratory Journal 35.3 (2010): 619-626. Web. 28 Feb. 2021.

  7. Torres, A.

    1. Torres, A., and R. Menéndez. "Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?." European Respiratory Journal 35.3 (2010): 473-474. Web. 28 Feb. 2021.

  8. Tsai, H-T.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  9. Tsai, M-H.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  10. Tsai, M.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  11. Tsangaris, I.

    1. Tsangaris, I., S. Orfanos, and D. Bouros. "Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification." European Respiratory Journal 35.3 (2010): 700-701. Web. 28 Feb. 2021.

  12. Tse, P. S.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

U

  1. Ueland, T.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

V

  1. Vancheri, C.

    1. Vancheri, C. et al "Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology." European Respiratory Journal 35.3 (2010): 496-504. Web. 28 Feb. 2021.

  2. van de Borne, P.

    1. Naeije, R., and P. van de Borne. " From the authors: ." European Respiratory Journal 35.3 (2010): 705. Web. 28 Feb. 2021.

  3. van Hest, R.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  4. van Houtte, P.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  5. van Meerbeeck, J.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  6. Van Schil, P.E.

    1. Van Schil, P.E.. "Medical Management of the Thoracic Surgery Patient." European Respiratory Journal 35.3 (2010): 714. Web. 28 Feb. 2021.

  7. Vestbo, J.

    1. Briggs, A. H. et al "Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study." European Respiratory Journal 35.3 (2010): 532-539. Web. 28 Feb. 2021.

  8. von Baum, H.

    1. von Baum, H. et al "Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors." European Respiratory Journal 35.3 (2010): 598-615. Web. 28 Feb. 2021.

  9. Voswinckel, R.

    1. Wolff, J-C. et al "Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth." European Respiratory Journal 35.3 (2010): 655-666. Web. 28 Feb. 2021.

W

  1. Wagner, P.

    1. Matricardi, P. M. et al "Predicting persistence of wheezing: one algorithm does not fit all." European Respiratory Journal 35.3 (2010): 701-703. Web. 28 Feb. 2021.

  2. Wagner, P. D.

    1. Eagan, T. M. L. et al "Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study." European Respiratory Journal 35.3 (2010): 540-548. Web. 28 Feb. 2021.

  3. Wahn, U.

    1. Matricardi, P. M. et al "Predicting persistence of wheezing: one algorithm does not fit all." European Respiratory Journal 35.3 (2010): 701-703. Web. 28 Feb. 2021.

  4. Waller, D.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  5. Walravens, K.

    1. Allix-Béguec, C. et al "Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis." European Respiratory Journal 35.3 (2010): 692-694. Web. 28 Feb. 2021.

  6. Wang, C-K.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  7. Wang, X.

    1. Kamio, K. et al "Statins inhibit matrix metalloproteinase release from human lung fibroblasts." European Respiratory Journal 35.3 (2010): 637-646. Web. 28 Feb. 2021.

  8. Wat, K. I.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

  9. Watson, J. M.

    1. Abubakar, I. et al "Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population." European Respiratory Journal 35.3 (2010): 689-692. Web. 28 Feb. 2021.

  10. Watz, H.

    1. Holz, O. et al "SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects." European Respiratory Journal 35.3 (2010): 564-570. Web. 28 Feb. 2021.

  11. Weder, W.

    1. Scherpereel, A. et al "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma." European Respiratory Journal 35.3 (2010): 479-495. Web. 28 Feb. 2021.

  12. Welte, T.

    1. von Baum, H. et al "Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors." European Respiratory Journal 35.3 (2010): 598-615. Web. 28 Feb. 2021.

  13. Wensel, R.

    1. Wensel, R.. "From the authors:." European Respiratory Journal 35.3 (2010): 706. Web. 28 Feb. 2021.

  14. Wilhelm, J.

    1. Wolff, J-C. et al "Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth." European Respiratory Journal 35.3 (2010): 655-666. Web. 28 Feb. 2021.

  15. Wolff, J-C.

    1. Wolff, J-C. et al "Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth." European Respiratory Journal 35.3 (2010): 655-666. Web. 28 Feb. 2021.

  16. Wong, M. Y.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.

Y

  1. Yang, C-H.

    1. Wang, C-K. et al "Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes." European Respiratory Journal 35.3 (2010): 667-675. Web. 28 Feb. 2021.

  2. Yew, W. W.

    1. Chang, K. C. et al "Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?." European Respiratory Journal 35.3 (2010): 606-613. Web. 28 Feb. 2021.
Back to top
European Respiratory Journal: 35 (3)

Search Within This Issue

Jump to

Manage Table of content Alerts